Ignite Creation Date:
2024-05-06 @ 4:02 PM
Last Modification Date:
2024-10-26 @ 2:02 PM
Study NCT ID:
NCT04853576
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-12
First Post:
2021-04-16
Brief Title:
A Study Evaluating the Safety and Efficacy of EDIT-301 in Participants With Severe Sickle Cell Disease RUBY
Sponsor:
Editas Medicine Inc
Organization:
Editas Medicine Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-04
Start Date Type:
ACTUAL
Primary Completion Date:
2025-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-08
Completion Date Type:
ESTIMATED
First Submit Date:
2021-04-16
First Submit QC Date:
April 16 2021
Study First Post Date:
2021-04-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-04
Last Update Post Date:
2024-07-12
Last Update Post Date Type:
ACTUAL